Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
[18F]-CP18 is a radiopharmaceutical agent containing a DEVD (caspase-3 substrate recognition motif) peptide labeled with fluorine-18. It's designed as a PET imaging tracer for detecting apoptosis (programmed cell death) by targeting caspase-3 activity. The tracer clears rapidly through the renal system and has shown promise in preclinical models for imaging apoptotic cells. It is being evaluated as a PET imaging tracer for apoptosis, which could have applications in oncology.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on [18F]-CP18.